APOE and atherosclerosis: Treatment of Apoe−/− mice with this viral nucleoprotein markedly reduces atherosclerosis and induces a Tr1-type regulatory immune response characterized by enhanced IL-10 but reduced IFN-γ and IL-4 production [111].